# US 2025/0146070 A1 · Method for determining whether asc is included at high purity in adipose tissue-derived cell population

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146070 A1
- Document ID: US20250146070A1
- Status: Published application
- Kind: A1
- Application number: 18/836,724
- Filed: 2023-02-14
- Published: 2025-05-08
- Earliest claimed: 2022-02-15
- Assignees: Keio University
- Applicants: Keio University
- Inventors: Yukako URUGA; Yumiko MATSUBARA
- Web page: https://patentgrep.com/patent/US20250146070A1

## CPC

- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- C12N 5/0667: {Adipose-derived stem cells [ADSC]; Adipose stromal stem cells}
- C07K 14/435: from animals; from humans
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure provides a method capable of more conveniently determining at an earlier stage whether a cell population collected from a vertebrate animal adipose tissue has mesenchymal stem cells (ASCs) at high purity, a kit for determining it, etc. The present disclosure includes, for example, a method for determining whether a cell population derived from an adipose tissue collected from a vertebrate animal comprises mesenchymal stem cells (ASCs) at high purity, the method comprising detecting expression of one or more genes in the cell population.

## Claims

### Claim at position 1

-6. (canceled)

### Claim 7

A method for determining whether a cell population derived from an adipose tissue collected from a vertebrate animal comprises mesenchymal stem cells (ASCs) at high purity, the method comprising a step of detecting expression of one or more genes selected from ASC specific genes.

### Claim 8 (depends on 7)

The method according to claim 7, wherein when the expression of one or more genes selected from the gene group A or increased expression thereof is detected in the step, it can be determined the cell population in the step comprises mesenchymal stem cells (ASCs) at high purity.

### Claim 9 (depends on 7)

The method according to claim 7, wherein the cell population derived from an adipose tissue is a primary cultured cell population.

### Claim 10 (depends on 7)

The method according to claim 7, wherein the detection of the expression of one or more genes in the step is a detection using a gene microarray, PCR, or sequencing.

### Claim 11 (depends on 8)

The method according to claim 8, wherein the detection of the expression of one or more genes in the step is a detection using a gene microarray, PCR, or sequencing.

### Claim 12 (depends on 9)

The method according to claim 9, wherein the detection of the expression of one or more genes in the step is a detection using a gene microarray, PCR, or sequencing.

### Claim 13 (depends on 7)

The method according to claim 7, wherein the detection of the expression of one or more genes in the step is performed using a primer and/or a probe for detecting expression of mRNA or cDNA of the one or more genes, or a labeled form thereof.

### Claim 14 (depends on 8)

The method according to claim 8, wherein the detection of the expression of one or more genes in the step is performed using a primer and/or a probe for detecting expression of mRNA or cDNA of the one or more genes, or a labeled form thereof.

### Claim 15 (depends on 9)

The method according to claim 9, wherein the detection of the expression of one or more genes in the step is performed using a primer and/or a probe for detecting expression of mRNA or cDNA of the one or more genes, or a labeled form thereof.

### Claim 16 (depends on 7)

The method according to claim 7, wherein the one of more genes are selected from the group consisting of SFRP2 (secreted frizzled-related protein 2) gene, PTGIS (prostaglandin 12 (prostacyclin) synthase) gene, PRG4 (proteoglycan 4) gene, MFAP5 (microfibrillar associated protein 5) gene, CRABP2 (cellular retinoic acid binding protein 2) gene, HAS1 (hyaluronan synthase 1) gene, CXCL1 (chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)) gene, CXCL5 (chemokine (C-X-C motif) ligand 5) gene, CRLF1 (cytokine receptor-like factor 1) gene, SPON1 (spondin 1, extracellular matrix protein) gene, CXCL6 (chemokine (C-X-C motif) ligand 6) gene, S100A16 (S100 calcium binding protein A16) gene, DPT (dermatopontin) gene, MASP1 (mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)) gene, CXCL8 (chemokine (C-X-C motif) ligand 8) gene, ACKR3 (atypical chemokine receptor 3) gene, GFPT2 (glutamine-fructose-6-phosphate transaminase 2) gene, IL1RN (interleukin 1 receptor antagonist) gene, PDE4D (phosphodiesterase 4D, cAMP-specific) gene, FBLN2 (fibulin 2) gene, CHI3L1 (chitinase 3-like 1 (cartilage glycoprotein-39) gene, NR4A1 (nuclear receptor subfamily 4, group A, member 1) gene, PID1 (phosphotyrosine interaction domain containing 1) gene, ACKR4 (atypical chemokine receptor 4) gene, IL6 (interleukin 6) gene, ID3 (inhibitor of DNA binding 3, dominant negative helix-loop-helix protein) gene, PTGFRN (prostaglandin F2 receptor inhibitor) gene, EPB41L3 (erythrocyte membrane protein band 4.1-like 3) gene, PENK (proenkephalin) gene, ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein) gene, HMCN1 (hemicentin 1) gene, HS3ST3B1 (heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1) gene, PDPN (podoplanin) gene, HES1 (hes family bHLH transcription factor 1) gene, NDNF (neuron-derived neurotrophic factor) gene, KIAA1549L (KIAA1549-like) gene, LRRC15 (leucine rich repeat containing 15) gene, DNASE1L3 (deoxyribonuclease I-like 3) gene, GAS7 (growth arrest-specific 7) gene, FNDC1 (fibronectin type III domain containing 1) gene, TWIST2 (twist family bHLH transcription factor 2) gene, IRAK3 (interleukin 1 receptor associated kinase 3) gene, SYNPO (synaptopodin) gene, CBS (cystathionine-beta-synthase) gene, MFAP2 (microfibrillar associated protein 2) gene, BMP4 (bone morphogenetic protein 4) gene, MXRA5 (matrix-remodelling associated 5) gene, MMP12 (matrix metallopeptidase 12) gene, CPXM1 (carboxypeptidase X (M14 family), member 1) gene, SGCD (sarcoglycan delta) gene, SIPA1L3 (signal-induced proliferation-associated 1 like 3) gene, TBX5 (T-box 5) gene, PTPRN (protein tyrosine phosphatase, receptor type, N) gene, JAM2 (junctional adhesion molecule 2) gene, ID2 (inhibitor of DNA binding 2, dominant negative helix-loop-helix protein) gene, and ITPR3 (inositol 1,4,5-trisphosphate receptor, type 3) gene.
